絞り込み

16767

広告

[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

著者 Unterecker S , Hefner G , Baumann P , Gründer G , Bergemann N , Clement HW , Conca A , Deckert J , Domschke K , Eckermann G , Egberts K , Gerlach M , Greiner C , Haen E , Havemann-Reinecke U , Helmer R , Janssen G , Jaquenoud E , Laux G , Messer T , Mössn
Nervenarzt.2018 Nov 16 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (8view , 0users)

Full Text Sources

Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood serum or plasma to optimize pharmacological therapy. TDM is an instrument with which the high interindividual variability of pharmacokinetics of patients can be identified and therefore enables a personalized pharmacotherapy. In September 2017 the TDM task force of the Working Group for Neuropsychopharmacology and Pharmacopsychiatry (AGNP) published an update of the consensus guidelines on TDM published in 2011. This article summarizes the essential statements for the clinical practice in psychiatry and neurology.
PMID: 30446893 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード